FBLG with nice breakoutLooks to be moving out of a falling wedge on some nice volume.
Looking long here to 3$+
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.3371 USD
−11.16 M USD
0.00 USD
29.68 M
About FibroBiologics, Inc.
Sector
Industry
CEO
Peter O'Heeron
Website
Headquarters
Houston
Founded
2021
FIGI
BBG01K4MB400
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of FBLG is 0.8401 USD — it has increased by 1.58% in the past 24 hours. Watch FibroBiologics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange FibroBiologics, Inc. stocks are traded under the ticker FBLG.
FBLG stock has fallen by −10.40% compared to the previous week, the month change is a 5.92% rise, over the last year FibroBiologics, Inc. has showed a −90.68% decrease.
We've gathered analysts' opinions on FibroBiologics, Inc. future price: according to them, FBLG price has a max estimate of 16.00 USD and a min estimate of 4.00 USD. Watch FBLG chart and read a more detailed FibroBiologics, Inc. stock forecast: see what analysts think of FibroBiologics, Inc. and suggest that you do with its stocks.
FBLG reached its all-time high on Jan 31, 2024 with the price of 55.0000 USD, and its all-time low was 0.7626 USD and was reached on Apr 9, 2025. View more price dynamics on FBLG chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
FBLG stock is 10.48% volatile and has beta coefficient of 0.55. Track FibroBiologics, Inc. stock price on the chart and check out the list of the most volatile stocks — is FibroBiologics, Inc. there?
Today FibroBiologics, Inc. has the market capitalization of 34.63 M, it has decreased by −19.38% over the last week.
Yes, you can track FibroBiologics, Inc. financials in yearly and quarterly reports right on TradingView.
FibroBiologics, Inc. is going to release the next earnings report on May 28, 2025. Keep track of upcoming events with our Earnings Calendar.
FBLG earnings for the last quarter are −0.09 USD per share, whereas the estimation was −0.09 USD resulting in a 2.17% surprise. The estimated earnings for the next quarter are −0.11 USD per share. See more details about FibroBiologics, Inc. earnings.
FibroBiologics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
FBLG net income for the last quarter is −3.10 M USD, while the quarter before that showed −500.00 K USD of net income which accounts for −519.80% change. Track more FibroBiologics, Inc. financial stats to get the full picture.
No, FBLG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 8, 2025, the company has 13 employees. See our rating of the largest employees — is FibroBiologics, Inc. on this list?
Like other stocks, FBLG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FibroBiologics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FibroBiologics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FibroBiologics, Inc. stock shows the sell signal. See more of FibroBiologics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.